ZELTA ECOA

Connect clinical trial participants, sites, and sponsors

A single, secure cloud platform that includes eCOA/ePRO and eConsent technology.

OVERVIEW

Engage directly with clinical trial participants

Zelta’s electronic clinical outcomes assessment (eCOA) and electronic patient-reported outcomes (ePRO) technology enables clinical trial participants to submit reliable data with ease and convenience – entering diaries, surveys, and assessments wherever and whenever required. Trial managers can design patient-centric clinical trials that enhance the user experience, reduce administrative burden, and improve patient adherence.

eCOA/ePRO
eConsent

Patient-friendly approach

Make it convenient for patients to record data via computer, tablet, or smartphone.

Accessible and scalable

Leverage eCOA built directly into a cloud-based unified platform that is accessible via single sign-on for all of your trials.

Real-time results

Monitor participant adherence and reported results real-time.

Deliver the best experiences for clinical trial participants and site personnel

Zelta eCOA/ePRO: Boost patient engagement

Data gathered directly from participants, including diaries, surveys, and assessments, is instantly available in Zelta EDC.
Improve patient experience and adherence with an ePRO app that’s convenient and easy to use via mobile (iOS or Android) or web.
Reach participants and sites anywhere in the world.

Zelta eConsent: Quickly consent participants wherever they are

Maximize site efficiency and remote management of participant consent.
Manage eConsent directly from Zelta’s cloud-based platform, alongside the eCOA/ePRO module.
Track amendments, consent status, and timelines in a dedicated dashboard.
Increase participant convenience with single sign-on access to both eConsent and eCOA/ePRO.

Explore Zelta eConsent

eCOA and ePRO unleash the benefits of decentralized trials

Decentralized clinical trials (DCTs) offer several benefits for CROs and sponsor companies, including reduced need for site travel, lowered trial costs, and better patient-reported outcome data for analysis.

Enabling trial participants to report outcomes via ePRO or using eConsent can greatly improve the patient experience, boost recruitment for trial managers, and allow real-time data capture. To date, the Zelta platform – including eCOA, ePRO, eConsent, and other modules – has been used to successfully build, run, and support over 250 hybrid trials or DCTs.

How Zelta supports DCTs

RESOURCES